PJP vs. PPH
PJP (Invesco Dynamic Pharmaceuticals ETF) and PPH (VanEck Pharmaceutical ETF) are both Health & Biotech Equities funds - PJP tracks the Dynamic Pharmaceuticals Intellidex Index while PPH tracks the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 10 years, PJP returned 7.25%/yr vs 8.33%/yr for PPH. Their correlation of 0.83 suggests significant overlap in exposure. PJP charges 0.58%/yr vs 0.36%/yr for PPH.
Performance
PJP vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 7.87% return, which is significantly higher than PPH's 1.11% return. Over the past 10 years, PJP has underperformed PPH with an annualized return of 7.25%, while PPH has yielded a comparatively higher 8.33% annualized return.
PJP
- 1D
- 0.70%
- 1M
- 3.08%
- YTD
- 7.87%
- 6M
- 4.83%
- 1Y
- 42.28%
- 3Y*
- 15.13%
- 5Y*
- 8.22%
- 10Y*
- 7.25%
PPH
- 1D
- 0.92%
- 1M
- -1.45%
- YTD
- 1.11%
- 6M
- 1.61%
- 1Y
- 21.33%
- 3Y*
- 11.87%
- 5Y*
- 9.48%
- 10Y*
- 8.33%
PJP vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 7.87% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
PPH VanEck Pharmaceutical ETF | 1.11% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between PJP and PPH is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.81 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.76 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.83 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2005 | 0.83 |
The correlation between PJP and PPH has been stable across timeframes, ranging from 0.76 to 0.83 - a consistent structural relationship.
PJP vs. PPH - Sectors Allocation Comparison
Sectors
PJP
PPH
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
PPH
Financial Services
PJP
PPH
-
Basic Materials
PJP
-
PPH
-
Communication Services
PJP
-
PPH
-
Consumer Cyclical
PJP
-
PPH
-
Consumer Defensive
PJP
-
PPH
-
Energy
PJP
-
PPH
-
Industrials
PJP
-
PPH
Real Estate
PJP
-
PPH
-
Technology
PJP
-
PPH
-
Utilities
PJP
-
PPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. PPH — Risk / Return Rank
PJP
PPH
PJP vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PJP | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.35 | ||
| Sortino ratioReturn per unit of downside risk | +1.70 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.22 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 4.50 | 1.99 | +2.51 |
| Martin ratioReturn relative to average drawdown | 14.26 | 4.86 | +9.40 |
Loading charts...
Drawdowns
PJP vs. PPH - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for PJP and PPH.
Loading charts...
Drawdown Indicators
| PJP | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -51.45% | +14.39% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -10.76% | +1.32% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -18.06% | +1.79% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -20.26% | +2.75% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -29.70% | -4.25% |
Current DrawdownCurrent decline from peak | -1.26% | -6.61% | +5.35% |
Average DrawdownAverage peak-to-trough decline | -8.83% | -17.29% | +8.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.97% | 4.40% | -1.43% |
Volatility
PJP vs. PPH - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.20%, while VanEck Pharmaceutical ETF (PPH) has a volatility of 6.13%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.20% | 6.13% | -0.93% |
Volatility (6M)Calculated over the trailing 6-month period | 12.34% | 12.15% | +0.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.54% | 17.61% | -1.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.19% | 15.15% | +1.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 17.01% | +1.38% |
PJP vs. PPH - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is higher than PPH's 0.36% expense ratio.
Dividends
PJP vs. PPH - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 1.19%, less than PPH's 2.08% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 1.19% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
PPH VanEck Pharmaceutical ETF | 2.08% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
PJP and PPH have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (6.13%) compared to PJP (5.20%). In terms of maximum drawdown, PJP dropped -37.06% vs PPH's -51.45%.
On 10-year performance, PPH leads with 8.33% vs 7.25% for PJP. On fees, PPH is cheaper at 0.36% per year. On volatility, PJP has been the lower-risk option at 5.20%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PPH has performed better with a 8.33% return vs 7.25%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.58% for PJP.
PPH has the higher dividend yield at 2.08%, compared with 1.19% for PJP.
PJP tracks Dynamic Pharmaceuticals Intellidex Index, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Invesco and VanEck. Their fees differ too: 0.58% for PJP and 0.36% for PPH.
PJP currently has the higher Sharpe Ratio (2.57 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer